272 related articles for article (PubMed ID: 12097329)
1. Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation.
Carmichael J; Sugars KL; Bao YP; Rubinsztein DC
J Biol Chem; 2002 Sep; 277(37):33791-8. PubMed ID: 12097329
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin.
Wyttenbach A; Sauvageot O; Carmichael J; Diaz-Latoud C; Arrigo AP; Rubinsztein DC
Hum Mol Genet; 2002 May; 11(9):1137-51. PubMed ID: 11978772
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.
Nemoto T; Kanai T; Yanagita T; Satoh S; Maruta T; Yoshikawa N; Kobayashi H; Wada A
Eur J Pharmacol; 2008 May; 586(1-3):82-9. PubMed ID: 18395711
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.
Kaga S; Zhan L; Altaf E; Maulik N
J Mol Cell Cardiol; 2006 Jan; 40(1):138-47. PubMed ID: 16288908
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
6. Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity.
Bijur GN; Jope RS
J Neurochem; 2000 Dec; 75(6):2401-8. PubMed ID: 11080191
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of glycogen synthase kinase-3beta is sufficient for airway smooth muscle hypertrophy.
Deng H; Dokshin GA; Lei J; Goldsmith AM; Bitar KN; Fingar DC; Hershenson MB; Bentley JK
J Biol Chem; 2008 Apr; 283(15):10198-207. PubMed ID: 18252708
[TBL] [Abstract][Full Text] [Related]
8. The proinvasive activity of Wnt-2 is mediated through a noncanonical Wnt pathway coupled to GSK-3beta and c-Jun/AP-1 signaling.
Le Floch N; Rivat C; De Wever O; Bruyneel E; Mareel M; Dale T; Gespach C
FASEB J; 2005 Jan; 19(1):144-6. PubMed ID: 15507471
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
10. Presenilin 1 regulates beta-catenin-mediated transcription in a glycogen synthase kinase-3-independent fashion.
Palacino JJ; Murphy MP; Murayama O; Iwasaki K; Fujiwara M; Takashima A; Golde TE; Wolozin B
J Biol Chem; 2001 Oct; 276(42):38563-9. PubMed ID: 11504726
[TBL] [Abstract][Full Text] [Related]
11. IL-6 augmented motility of airway epithelial cell BEAS-2B via Akt/GSK-3β signaling pathway.
Wang WC; Kuo CY; Tzang BS; Chen HM; Kao SH
J Cell Biochem; 2012 Nov; 113(11):3567-75. PubMed ID: 22740511
[TBL] [Abstract][Full Text] [Related]
12. Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization.
Neelam S; Brooks MM; Cammarata PR
Mol Vis; 2014; 20():1758-75. PubMed ID: 25593505
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
Wang HM; Zhang T; Li Q; Huang JK; Chen RF; Sun XJ
Neurochem Int; 2013 Nov; 63(5):345-53. PubMed ID: 23871716
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activity of glycogen synthase kinase-3beta: positive regulation of steady-state levels of insulin receptor substrates-1 and -2 in adrenal chromaffin cells.
Nemoto T; Yokoo H; Satoh S; Yanagita T; Sugano T; Yoshikawa N; Maruta T; Kobayashi H; Wada A
Brain Res; 2006 Sep; 1110(1):1-12. PubMed ID: 16870161
[TBL] [Abstract][Full Text] [Related]
16. The effects of GSK-3β blockade on ketamine self-administration and relapse to drug-seeking behavior in rats.
Huang X; Huang K; Zheng W; Beveridge TJ; Yang S; Li X; Li P; Zhou W; Liu Y
Drug Alcohol Depend; 2015 Feb; 147():257-65. PubMed ID: 25497591
[TBL] [Abstract][Full Text] [Related]
17. Role of GSK-3beta activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene.
Koh SH; Lee YB; Kim KS; Kim HJ; Kim M; Lee YJ; Kim J; Lee KW; Kim SH
Eur J Neurosci; 2005 Jul; 22(2):301-9. PubMed ID: 16045483
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
19. Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction.
Zhang L; Cen L; Qu S; Wei L; Mo M; Feng J; Sun C; Xiao Y; Luo Q; Li S; Yang X; Xu P
PLoS One; 2016; 11(4):e0152931. PubMed ID: 27045591
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3beta regulates DeltaNp63 gene transcription through the beta-catenin signaling pathway.
Chu WK; Dai PM; Li HL; Chen JK
J Cell Biochem; 2008 Oct; 105(2):447-53. PubMed ID: 18615589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
